A favorite topic of mine over the years is Japan. In this column, I have covered different aspects of the Japanese pharmaceutical industry and biotech markets (3/10/03, 8/18/03, 3/28/05). I had the good fortune to return to Japan for the Bio-Jan 2006 Conference
in September after a three-yea......Full article >>>
Mayor Daley's head of transportation accompanied us on this trip to Japan and came away wowed by the Japanese approach to mass transit. Many more people in Japan use mass transit, a combination of an extensive network of easy-to-use subways and trains, including the high-speed bullet trains - the Shinkansen - than in Chicago.
Upon arriving to Osaka for the Bio-Japan Conference, att......Full article >>>
e over-the-counter (OTC) drugs.
This level compares with the U.S. market, which had pharmaceutical sales of $240.3 billion in 2005, represented 44 percent of the total market, and grew three percent. So the U.S. market is about four times as large as the Japanese market, but remember that the U.S. population is about three times that of Japan (the Japanese population, at about 127 million......Full article >>>
but bi-annual price reductions of eight to 12 percent (although there is talk of reducing prices on an annual basis.) This is another factor driving Japanese companies to merge for greater critical mass (particularly in R&D) and expand their presence in the United States.
The Japanese pharma industry has been slow to embrace the successful pathway used by its automotive counterparts. Neve......Full article >>>
|Shionogi & Co. (Osaka)||$1.7||<1%>||$0.2||+20%|
|49||Dainippon Sumitomo Pharma Co. ** (Osaka)||New Jersey||$1.6||+30%||$0.1||122%|
Source: MedAd News
, Sept. 2006
*now owned by Hoffman LaRoche
**represents merger during last 2 years
Note: sales number vary slig......Full article >>>
Full article >>>
ties have gotten on the biotech bandwagon. University professors now are allowed to spend time with start-up companies and share in revenue from out-licensed technologies.
What struck me at the Bio-Japan meeting was the lack of Japanese "Big Pharma" presence at the meeting (very few were there). They seem to be missing out on the growth of their own home-grown market as a source of innova......
Full article >>>
lly, the Japanese External Trade Office has a large regional presence in the Midwest with its Chicago office. JETRO played a major role at the Bio-Japan event, fostering partnering sessions and receptions.
I think the time is right for Illinois and the Midwest to build further ties to both the Japanese biotech industry and the second and third tier Japan......
Full article >>>
hnology Network, LLC. (WTN). WTN, LLC, accepts no legal liability or responsibility for any claims made or opinions expressed herein.......
Full article >>>
Source:wistechnology.com By Michael Rosen 10/23/06
Related biology technology :
1. Japanese delegates highlight Wisconsin at BIO Chicago
2. Japanese telecom opens liason office at UW-Platteville
3. Promega, Japanese lab announce partnership
4. Japanese institute installs Imago system
5. Wisconsin biotechs plan Japan trade mission
6. Sonic Foundry makes Japanese version of lead product
7. OpGen forges agreement with Japanese importer
8. Japanese biotech is booming and linked with Midwest
9. Japans pharma mergers will trickle to the Midwest
10. Japanese institute will develop for UWs Croquet platform
11. Doyles Japan trip opens doors and minds for Wisconsin
(Date:2/22/2017)... 22, 2017 Aethlon Medical, Inc. (Nasdaq: ... study that validated the ability of the Aethlon Hemopurifier® ... increased mortality in immune-suppressed sepsis patients and also contribute ... The objective of the study was to validate the ... virus (EBV) and Herpes Simplex virus 1 (HSV1) by ...
(Date:2/22/2017)... PARK, N.C., Feb. 22, 2017 United Therapeutics Corporation ... financial results for the fourth quarter and year ... financial results reflect continued growth as net revenues ... said Martine Rothblatt, Ph.D., United Therapeutics, Chairman and ... ability to develop and advance our growing product ...
(Date:2/21/2017)... ... February 21, 2017 , ... ... Liquid Biopsy System , a fully automated benchtop system for collecting intact circulating ... is being launched at the Molecular Medicine Tri Conference (Tri-Con) Annual Meeting 2017 ...
(Date:2/21/2017)... , ... February 21, 2017 ... ... Life -Sciences division, Treximo will pair its $200M operational capacity with its ... and project management in areas affecting quality and operational management. With ... Breaking Biology Technology:
(Date:2/10/2017)... DUBLIN , Feb 10, 2017 ... PharmaBiotech,s new report "Personalized Medicine - Scientific and Commercial ... ... in personalized medicine. Diagnosis is integrated with therapy for selection ... emphasis on early detection and prevention of disease in modern ...
(Date:2/8/2017)... Feb. 7, 2017 Report Highlights ... The global synthetic-biology market ... billion by 2021, growing at a compound annual growth rate ... overview of the global markets for synthetic biology. - Analyses ... 2016, and projections of compound annual growth rates (CAGRs) through ...
(Date:2/7/2017)... 7, 2017 Zimmer Biomet Holdings, Inc. (NYSE ... will present at the LEERINK Partners 6th Annual Global ... on Wednesday, February 15, 2017 at 10 a.m. Eastern ... presentation can be accessed at http://wsw.com/webcast/leerink28/zbh . The ... via Zimmer Biomet,s Investor Relations website at http://investor.zimmerbiomet.com ... Breaking Biology News(10 mins):